DayOne Accelerator, now in its six edition, has supported a total of 38 truly healthtech startups, enabling them to raise funding and get access to industry players. For this year, the selection panel selected 15 companies from a total of 170 submissions from countries worldwide. The theme of this year’s accelerator program is “Harnessing AI, data and digital tools to power clinical development”. Under this theme, the 2024 cohort is spread across the four main areas of interest: elevating patient experience, ehanhancing patient’s identification access, advancing digital and imaging endpoints, and streamliing operations.
Three of the 15 sleected startups are from Switzerland:
Exploris Health is a Zurich-based AI company developing Multi-Omic-Marker Algorithms to diagnose complex diseases and provide personalized treatment recommendations. The goal is to improve patient outcomes while reducing costs of providers and healthcare systems.
TOM Medications, developed by Innovation 6 AG, is a mobile app that facilitates tracking and adherence to medications. By involving patients early in the clinical development phase and iterating continuously, TOM creates a real-world data supply chain from clinical trials to post-marketing, paving the way for more accurate and effective healthcare solutions.
Wemedoo, headquartered in Steinhausen (Zug) provides unified software solutions for clinical research and practice. We integrate all clinical trial tools into a single, comprehensive system and enable digitized treatment paths, workflows, and disciplines. Our clients leverage real-time data, seamless collaboration, and AI across healthcare to achieve superior clinical advancements.
A list with all 15 selected start-ups was published on the DayOne website.
Phase 1 kicks off
The startups in the six-month hybrid accelerator program are kicking off with Phase 1 program, to help them optimize the value proposition and business model of their startup. DayOne will also set them up with valuable connections with fellow startups, mentors, experts, and the various accelerator program sponsors. At the end of the year, five of the 15 startups will be selected to advance to Phase 2, where they will work towards scaling up their business and achieving pivotal milestones. They will receive tailored mentoring and expert support, as well as in-kind services offered by DayOne and its supporting sponsors, to prepare them for collaborations with the life science industry.
(Press release/RAN)
Image by FreePik